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INTRODUCTION
Diabetes mellitus is often recognized as a metabolic disease that
depresses the anti-bacterial defenses of the host.

Many clinical in-

vestigators have reported that patients with uncontrolled diabetes are
unusually susceptible to bacterial disease.
It appears that in the diabetic patient the function of leukocytes
in inflammation is impaired.

A decrease in glycolysis, inability of the

diabetic leukocyte to phagocytize and a defect in leukotaxis can play a
role in abnormal leukocyte function.

These abnormalities of the leukocyte

could contribute to increased infections in the uncontrolled diabetic patient.
The evidence that diabetes mellitus is related to functional disorders of neutrophils suggested the study of inflammation in streptozotocin
induced diabetes mellitus.

This study measures the neutrophilic infiltra-

tion in a simple mucosal wound in rats and the detection of nitroblue tetrazoleum reaction of blood neutrophils within oral tissue of non-diabetic
and diabetic rats.
Since it has been shown that diabetics exhibit delayed healing when
compared to non-diabetics, it is hoped that this investigation will assist
in understanding the importance of polymorphonuclear leukocyte count during healing of the excised wound.
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LITERATURE REVIEW
Diabetes mellitus is a hereditary or developmental disorder characterized by an abnormally high level of glucose in the blood.

The basic

defect is an absolute or relative lack of insulin which leads to abnormalities of carbohydrate, protein and fat metabolism. 1
Blood sugar is normally maintained in a range approximately 80 to
120 mg/dl. 2 Values below this range reflect hypoglycemia, whereas values
above the range reflect hyperglycemia.

Diabetes mellitus is a disease in

which a fluctuating and often persistent hyperglycemia results in a loss
of glucose homeostasis.

Since insulin helps to control the cellular uptake

of glucose, diabetes mellitus has occasionally been defined as a relative
or absolute insulin deficiency.
Insulin is normally produced by the beta cells within the pancreatic
islets of Langerhans.
of preproinsulin.

Active insulin is made by progressive modification

A rise in the concentration of blood glucose is a pri-

mary signal for secretion of insulin.

The classic result of insulin action

is a dramatic increase in the rate of transport of glucose into skeletal
muscle and adipose tissue.

Insulin also promotes the uptake of amino acids

by skeletal muscles and increases protein synthesis.

It accelerates lipid

synthesis and inhibits lipolysis and gluconeogenisis. 3 Lack of insulin
may result from diminished production of insulin, faulty release of insulin, antibodies to insulin and/or abnormalities of the body•s cells
precluding normal action of insulin. 4 Human insulin is a small protein
2

3

with a molecular weight of 5808 and is composed of two amino acid side
chains, connected by disulfide bridges.

An important effect of insulin is

its ability to increase the rate of glucose transport through the membranes
of most cells in the body.

In the complete absence of insulin, the over-

all rate of glucose transport becomes only one fourth the normal value. 5
The diabetic, therefore, has high levels of blood glucose with deficient
cellular glucose.

Because of cellular glucose deficiency, the diabetic

relies on lipids for energy, with excessive production of acetylcoenzyme A
and ketone bodies resulting in acidosis.

Coenzyme A enhances the produc-

tion of cholesterol, which, in turn, may be partially responsible for the
increased frequency of severe atherosclerosis in diabetics. 6
The pathology of diabetes mellitus may be related to one or more of
the following three major effects of insulin lack: (1) decreased utilization
of glucose by the body cells, with a resultant increase in blood glucose
concentration; (2) markedly increased mobilization of fats from storage
areas, causing abnormal fat metabolism and especially deposition of lipids
in vascular walls to cause atherosclerosis; and (3) depletion of protein
in the tissues of the body. 5
Patients with diabetes mellitus exhibit polydipsia (excessive drinking), polyuria (excessive elimination of urine), polyphagia (excessive
eating), loss of weight and asthemia (lack of energy) as the earliest symtoms of the disease.

Polydipsia and polyuria are due to the hyperosmolal-

ity of the blood, which results from the increased glucose levels.

Gen-

eralized weakness, increased tendency to infection and poor wound healing
are also commonly present in the initial

stages.~

These symptoms of
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diabetes are related to excess blood glucose and also to increased breakdown of lipids, resulting in acidosis.
Diabetes may be experimentally produced in laboratory animals with
injection of streptozotocin.

Streptozotocin is an antibiotic extracted

from Streptomyces acromogenes. 7

In 1963, Rakieten, et al., reported that

streptozotocin is diabetogenic, since its intravenous administration led
to diabetes in dogs and rats.

They found that the diabetes was attributed

to damage of the pancreatic B-cells.

Junod, et al., (1963) found in their

study that streptozotocin is an effective cytotoxic agent for pancreatic
B cells.

They found that the action occurs early, having found histologic

evidence after 1 hour, and intense necrosis strictly limited to B-cells
evident at 7 hours. 7
Diabetes mellitus is often recognized as a metabolic disease that
depresses the antibacterial defenses of the host.

Many clinical investi-

gators have reported that patients with uncontrolled diabetes are unusually
susceptible to bacterial disease.

Leukocytes differ from other body cells

in that they have the capacity to migrate, contain few mitochondria and
metabolize glucose primarily to lactic acid.

As human diabetes mellitus

is expressed in abnormalities of carbohydrate, lipid and protein metabolism1, any resulting inefficient neutrophil bactericidal and/or leukotaxis
mechanisms may be partly responsible for the increased susceptibility of
patients with diabetes mellitus to infection.
The polymorphonuclear leukocytes are the most abundant of the leukocytes, constituting 55% to 65% of the total count.

There are about 3,000

to 6,000 per cu. mm. or 20 to 30 billion in the circulation at any one

5

time.

They are 10 to 12 microns in diameter and are easily recognized by

their highly characteristic nucleus consisting of two or more lobules
connected by narrow strands. 6
The neutrophil is an end cell of myeloid differentiation and does
not divide.

The neutrophils arise in the bone marrow from a common an-

cestral stem cell, and after a series of divisions, undergo a maturation
through a myeloblast, promyelocyte, metamyelocyte, band cell and mature
PMN.

After a short period in the blood (about 12 hours), the PMN•s enter

the tissues where they complete their life span of a few days. 8
With the maturation of the cells, there is an ·appearance of two distinct classes of granules: the primary (azurophilic) and the secondary or
specific granules.

The primary granules are electron-dense structures

approximately 0.4 microns in diameter that appear early in maturation.
They contain myeloperoxidase, arginine-rich basic (cationic) proteins,
sulfated mucopolysaccharides, acid phosphatase and other acid hydrolases.
The secondary or specific granules are not truly lysosomes; they are smaller and less dense than primary granules.
phate, lysozyme and aminopeptidase.

They are rich in alkaline phos-

As maturation proceeds, the secondary

granules increase in number and appear to predominate.

Both types of

granules are important in the breakdown of ingested material and in the
killing of microorganisms. 8
The life span of the neutrophils in the circulatory system is about
seven hours.

During times of tissue injury these cells can squeeze through

the endothelial cells of the blood vessels by the process of diapedesis.
Once the cells have entered the tissue spaces they move through the
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tissues by ameboid movement.

In the tissues, the neutrophils average a

life span of eleven days.
The mature PMN is highly specialized for the performance of its
primary function, the phagocytosis and destruction of microorganisms.
Several functions are required in order for the neutrophil to perform its
task of phagocytizing foreign matter.

First, the cells must reach the

site of the foreign configuration by chemotaxis.
the foreign substance by phagocytosis.

They must then ingest

Finally, after a series of meta-

bolic steps, they must destroy the foreign substance or inhibit the replication of the microorganism by microbial killing. 8
The killing of microorganisms is the primary purpose of the phagocytic system.

The formation of an inflammatory exudate, composed primarily

of neutrophils and monocytes, occurs rapidly in response to a local infection.9 Tissue damage initiates some form of stimulus which produces the
following series of events. Neutrophils begin to marginate along the capillary and venule walls in the area of tissue damage and commence to
diapedese between the endothelial cells lining the walls.

The cells are

held up for some time at the basement membrane and then move through this
and on toward the damaged area to which they are attracted by a chemotactic stimulus. 9
Chemotaxis appears to be mediated by substances which directly influence neutrophils, such as bacterial products or certain components of
complement {C5 , c3 and the c567 trimolecular complex) and by factors
which interact with plasma to activate complement such as antigen-antibody
complexes and lysosomal contents of phagocytes. 9

7

The trimolecular complex,

c567 ,

exists naturally in serum in an in-

active form and can be activated by interaction in series of the other
components of complement.

The activated complex causes intense accumula-

tion of polymorphonuclear leukocytes when injected intradermally into
rabbits.

The third component of complement can produce a fragment chem-

otactic for polymorphs when acted on by plasmin.

There are also various

chemotactic factors produced by bacteria such as Dipplococcus pneumoniae,
Staph. albus, Staph. areus and Streptococcus faecalis.
Once the polymorph has arrived at the inflammation site, it begins
its function of phagocytizing foreign matter.
is a very intricate process.

The process of phagocytosis

The phagocytosed material is not brought

directly in contact with the cytoplasm.

The ·cytoplasmic membrane invagin-

ates and encloses the phagocytosed material within a membrane limited
vacuole.

Once the organism is taken up within the cell, the phagosome

will come in contact with a lysosome and the two membranes will fuse.

The

lysosome will expel enzymes into the phagosome which are essential to the
destruction of the bacterium.

Before fusion with the phagosome the lyso-

some maintains a distance of 100 angstroms from the inner surface of the
cell membrane. 9 The collision of the lysosome with the phagosome appears
to be a 11 random hit 11 phenomena.
Recognition by the cell that the particle is foreign is essential
for phagocytosis to occur.
role.

The process of opsonization appears to play a

Opsonins include immunoglobulins, certain components of the comple-

ment system and other plasma factors.

9

The opsonin acts upon the parti-

cle to be phagocytized, not on the phagocyte.
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Exocytosis appears to be less understood but the release of metabolically active and theoretically damaging materials into areas of exudate
may contribute to tissue damage as well as being a chemotactic stimulus
for more cells. 9 A variety of secretory products are released from the
cell as a result of exocytosis.

Some of these enzymes include hyaluroni-

dase, ribonuclease, lysozymes, histamine, leukocyte pyrogen and vitamin

s12 binding protein. The extent of these various enzymes remains to be
investigated.
The metabolism of phagocytosis requires a modest expenditure of
energy which is supplied by glycolysis and associated with increased glucose utilization and lactate production.

Phagocytosis and lysosomal mer-

ger with the phagosome are followed by an energy burst derived primarily
from hexose monophosphate shunt (HMS) activation. 9
Associated with increased HMS activity is increased production of
hydrogen peroxide which, in the presence of myeloperoxidase, a constituent
primarily of lysosomes, provides a potent antibacterial mechanism for the
leukocyte. 9 The HMS is governed by the availability of NADP and the polymorph possesses several mechanisms for NADP regeneration.

The most prom-

inent pathway utilizes NADPH oxidase where H202 is an additional product
of the reaction.

The enzyme NADPH oxidase, gives rise to H202 and NAD,

increasing the activity in phagocytosing cells.

The H202 may also inter-

act with reduced glutathione and glutathione peroxidase to give rise to
oxidized glutathione which then may react with an NADPH linked glutathione
reductase forming NADP for stimulation of the hexose monophosphate shuntglycolytic pathway and reduced glutathione.

The antibacterial activity
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of the H2o2-myeloperoxidase system is enhanced by small amounts of halide
co-factors which in the case of iodide result in iodination of bacterial
proteins and, in the case of chloride result in decarboxylation and deamination of amino acids giving rise to toxic aldehydes. 9
Nitroblue tetrazolium (NBT) is an artificial electron acceptor which
is reduced by the PMN during the phagocytosis-induced metabolic burst. 11
A quantitative NBT test is based on the metabolic activity of the phagocyte that occurs with particle uptake and intracellular digestion.

The

increased flow of protons thru the HMS shunt during phagocytosis and intracellular digestion is measured calorimetrically by the reduction of
the nitroblue tetrazolium dye to a blue formazan pigment.

The NBT test

differentiates between the resting and phagocytosing states of neutrophils.
The quantitative NBT test is markedly depressed in cases in which there is
an impairment in metabolic activity of leukocytes, such as in chronic
granulomatous disease. 8
Various factors suggest themselves as the cause of the lowered resistance to infection in the diabetic.

These may be summarized as follows:

1)

Increased sugar content of blood tissues.

2)

Decreased activity of blood elements associated with
resistance to infection: (a) subnormal activity of
complement; (b) subnormal phagocytizing capacity of
leukocytes; (c) subnormal bacteriostatic and bactericidal action of whole blood.

3)

Inadequate functioning of fixed tissue cells.

4)

Lowered capacity of tissues to react to antigenic stimuli.

5)

Lowered state of general cellular nutrition. 12

Adherence of granulocytes may also play a role in susceptibility
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to infections in diabetics.

In studies of patients with poorly controlled

diabetes, with fasting hyperglycemia but not ketoacidosis, the mean values
for granulocyte adherence were significantly lower than for normal control
cells. 13
No impairment of immunological competence has been detected in diabetic patients, and deficiencies in cellular defense have been demonstrated
only in the presence of ketoacidosis, even though an insulin-correctable
depression of glycolysis has been noted in the leukocytes of nonacidotic
diabetics. 14
The susceptibility to infections in diabetics could also be due to
a delay in the granulocyte response.

Perillie 15 et. al., (1962) showed

that the early granulocyte phase of local cellular response was significantly delayed and diminished in patients with acidosis in comparison with
normal and nonacidotic patients.
Esmann 12 (1972) in his research on the diabetic leukocyte, concluded
that evidence points towards glucose being freely permeable to the cell
membrane.

He placed special importance on the crowding effect, i.e. the

decrease in metabolic rate observed by increasing the cell concentration,
in this respect.

Upon placing normal and diabetic cells in a bicarbonate

buffer at the same low concentration to avoid the crowding effect, he
found that the glycolysis of diabetic cells is decreased. Glucose-6-phosphate and fructose-6-phosphate accumulate in diabetes, suggesting a decreased activity of phosphofructokinase.

The increase in glucose-6-phos-

phate concentration is probably responsible for a small decrease in glucose utilization and a slight increase in pentose cycle activity as well
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as for an increase in the relative amount of glycogen synthetized.

In-

sulin in vivo corrects the metabolic alterations. 13
Martin 16 et. al., (1953) found that the cells of the diabetic subject
have a significantly lower {p. 0.01) production of lactic acid with glucose
and a significantly higher (p. 0.01) production with fructose. The utilization of glucose was significantly lower in the diabetic than in the
control group (p. 0.02).

There was a significant increase (p. 0.02) in

utilization of glucose in the diabetic group (0.18± 0.04 micromole) on the
addition of insulin. 16 Martin and his associates indicated that the leukocyte of the diabetic subject responds to insulin by increasing lactate
production.

The effect of the metabolic defect noted in the leukocytes

from subjects with diabetes mellitus may account for the alterations in
susceptibility to disease.

In an area of inflammation, the leukocyte of

the diabetic subject might be unable to utilize the available glucose to
produce bactericidal quantities of lactic acid. 13
Munroe and Shipp 1 (1965) in their research on leukocytes and diabetes
mellitus confirmed the results of others that the major fate of glucose in
human leukocytes was lactic acid production.

Glucose metabolism in leu-

kocytes from diabetics differed in two respects.

The per cent of glucose

uptake oxidized in the pentose cycle was increased in leukocytes from all
diabetics.

In the insulin-treated diabetics glucose uptake and lactic

acid formation were similar to controls.

In contrast, glucose uptake and

lactic acid formation were reduced in leukocytes from adult, latent, hypercholesteremic diabetics.
in diabetics and controls.

Pyruvate and acetate oxidation was similar
Thus, in terms of leukocyte metabolism,
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hypercholesteremia in the human diabetic was correlated with reduced glycolysis and not with reduced pentose cycle activity. 1
Dumm 17 (1957) only found reduced glucose utilization in cells from
patients with the most severe diabetes, and explained this finding by observing that plasma from diabetics was able to inhibit the glucose utilization of normal leukocytes.
Esmann 18 (1964) in his experiment on the effect of cell concentration
on the metabolism of normal and diabetic leukocytes in vitro, showed an
overall decrease of glucose uptake, lactic acid production and glycogen
synthesis in human diabetic leukocytes.
The marked increase in glycogen which occurs during the course of an
inflammatory response in normal animals is due to the high glycogen content of the invading leukocytes.

The glycogen content increases in the

diabetic animal to an even greater extent than in the normals, due to the
nature of the disease.

Because the leukocytes from diabetic animals were

found to have the same glycogen content as leukocytes from normal animals,
it appears that, once leukocyte invasion begins, more cells enter the experimental site per unit time and that the duration of leukocyte invasion
is increased, compared to nondiabetic animals. 19
Dumm 17 (1957) found that although glucose utilization by leukocytes
from diabetic humans was impaired, there was no reduction in lactate production.
Insulin binds to the surface of leukocytes.

The effect of insulin

in vitro on glucose utilization and glycolysis has been sought for, but
with controversial results.

13
Martin 16 (1953) found an increased glucose utilization and lactic
acid formation with 0.1 U insulin/ml in diabetic, but not in normal cells.
Esmann 20 (1963) found a significant increase in glucose utilization,
lactate and glycogen formation after 24 hours of treatment of diabetic
patients with insulin.
The decreased rate of glycolysis in diabetic cells can be attributable to concentrations of essential enzymes.

The diabetic leukocytes

have high concentrations of glucose and fructose-6-phosphate, which are
normalized upon treatment of the patients with insulin.

This suggests a

decreased activity of the phosphofructokinase reaction in uncontrolled
diabetes and may explain the decreased rate of glycolysis found in diabetic cells. 13

Esmann attributes the limited Kreb's cycle activity to the

paucity of mitochondria in human polymorphonuclear leukocytes.
Marble 21 (1952) hypothesized that the subnormal phagocytizing capacity of the leukocyte was one of the possible causes of reduced resistance
of the diabetic to infection.
Wertman and Henney 22 (1961) in their study on phagocytosis in diabetic leukocytes indicated that the animals with alloxan-induced hyperglycemia had an impaired defense mechanism.

The rats with high concentrations

of blood sugar had not only a lower percentage of active neutrophils but
the activity of these cells was considerably reduced.

The alloxan diabetic

rat demonstrated an average of 45% and 42% active neutrophils and the rats
with a normal sugar concentration an average of 91%, 87% and 88%.

The

active neutrophil of the alloxan diabetic animal engulfed on the average
4 microorganisms per neutrophil as compared to 17 microorganisms per

14
neutrophil of the rat with a normal sugar concentration.

It appeared evi-

dent that rats injected with sufficient alloxan to cause hyperglycemia
were reduced in the capacity to phagocytize bacteria. 13
In 1974, Robertson and Polk, in their study on leukocyte malfunction
showed that hyperglycemia alone led to decreased phagocytosis, decreased
diapedesis and a decrease in intracellular killing of bacteria by PMN's.
They theorized that an intrinsic defect in the PMN was a cause of the malfunction.

They also found that there was no significant difference in

immunoglobulins A, G and Mon the surface of diabetic and normal PMN's;
and that the metabolic pathways are altered in diabetic PMN's which may
cause a malfunction in their ability to affect infectious organisms.
Bybee and Rogers 23 (1964), in their study on the phagocytic activity
of polymorphonuclear leukocytes obtained from patients with diabetes mellitus, suggest that PMN leukocytes obtained from nonacidotic diabetic patients exhibit normal phagocytic activity.

In contrast, leukocytes ob-

tained from diabetic patients in ketoacidosis showed suppression of their
ability to ingest a pathogenic Staphylococcus.
corrected when the acidosis was corrected.

This abnormality was

This quantitative decrease in

phagocytic capacity appeared to be the result of an abnormality of the
diabetic leukocyte.
Drachman 2 ~

et. al., (1966) showed that the phagocytic capabilities of

polymorphonuclear leukocytes are affected by the high levels of glucose in
the tissues of chronically diabetic rats. In the intact diabetic animal,
not only did the histological and quantitative bacteriological findings
suggest a depression of phagocytosis, but an impairment of in vivo

15

phagocytic activity was also demonstrated in a preformed inflammatory exudate.

Also noted was that the principal defect in the diabetic animals

resided in their serum rather than in their polymorphonuclear leukocytes.
The depressive factor in the serum was identified as the abnormally high
concentration of glucose.
Contrary work was shown by Miller and Baker 25 (1972).

Although hy-

perglycemia has been found to depress in vitro phagocytosis of pneumococci
in diabetic rats and poorly controlled diabetic patients, no correlation
between neutrophil function and blood glucose levels in juvenile diabetic
patients was demonstrated.
It has been reported that leukocytes from rabbits with acute alloxan
diabetes and acidosis had reduced bactericidal power for engulfed pneumococci.26 Richardson 27 (1933) felt that the reduced bactericidal power of
whole blood in his studies was directly related with the presence of acidosis.
The metabolic changes following phagocytosis have not been extensively investigated in diabetic leukocytes, but it has been reported that the
mobilization of glycogen during phagocytosis is impaired in alloxan-diabetic rat cells.

For the intracellular killing of bacteria, the formation of

H2o2 in the pentose cycle is of importance. It is, therefore, essential
that the normal increase in pentose cyc~e activity upon phagocytosis is
not impaired in diabetic rat or human leukocytes. 13
Cantonzaro-Guimaraes 28 (1968) noted that the diabetic animals exhibited an increased acute inflammatory cell population, primarily in the
form of PMN's.
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Leukocyte chemotaxis is the ability of the neutrophil to move unidirectionally toward an increasing chemotactic stimulus.

Many investiga-

tors have demonstrated impaired leukocyte chemotaxis in diabetes mellitus.
Steerman 29 et. al., (1971) described normal chemotaxis as a consequence of
chemotactic factors derived from serum interacting with cells capable of
responding to these factors.

He described impairment of chemotaxis as the

primary result of an intrinsic defect of polymorphonuclear leukocytes.
These impairments of PMN function were demonstrated by an inability of the
patient•s PMN•s to respond to chemotactic factors in •activated• whole
serum or in preparations of C5a.

Since these abnormalities were not cor-

rected by the addition of normal serum or plasma to the patient•s cells,
the deficiency in chemotaxis could not be accounted for solely by a deficiency of a humoral factor.

Steerman and associates also theorized that

since this patient had normal or elevated levels of haemolytic activity for
total complement and the individual components of C1 through C5 and failed
to show correction of PMN function with the addition of normal serum, that
it is improbable that an abnormality of the complement system is responsible for his defects in PMN function.
Miller 30 et. al., (1973) in his research on leukocyte mobility and
Lazy Leukocyte Syndrome (LLS), concluded that on the basis of current
knowledge of the mechanisms involved in chemotaxis and random mobility,
it seems possible that the basic defect in the familial disorder involves
specific chemotactic receptor(s), while that of the LLS may involve a less
specialized aspect of leukocyte integrity, perhaps a membrane defect.
Hill 31 et al., (1974) in their study on impaired leukocyte
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responsiveness in diabetes mellitus showed that leukocytes of patients
with juvenile onset diabetes mellitus responded less actively than controls in unidirectional movement toward a chemotactic stimulus.

Neither

abnormalities of serum concentrations of cholesterol, triglycerides, glucose and creatine, nor the duration of the diabetic state had an apparent
effect on the presence or severity of the leukotactic abnormality.
Ward and Becker 32 (1970) have shown that leukotaxis is impaired when
there is a depletion of intracellular potassium.

They theorized that in-

sulin, in the presence of glucose, may act upon enzyme systems resulting
in an influx of potassium and enhancing the ability of leukocytes of diabetics to respond to a chemotaxis stimulus.
Goetzl and Austen 33 (1974) found that several chemotactic factors
increased both aerobic glycolysis and metabolism through the hexose monophosphate shunt.

Their investigation indicates that suppression of both

the HMPS and glycolysis inhibits chemotactic migration of polymorphonuclear leukocytes.
A study of leukocyte functions in juvenile diabetes mellitus by
Miller and Baker 25 (1972) found that chemotaxis of polymorphonuclear leukocytes from children with juvenile diabetes who had received insulin was
not improved.

They explained the deficiency in generation of chemotactic

activity in that children might have increased amounts of circulating
antigen-antibody complexes due to the production of anti-insulin antibodies.

They theorized that these complexes might, then, activate the com-

plement system, thus resulting in less available complement molecules for
generation of chemotactic activity.
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Mowar and

Baum 3 ~

(1971) using an in vitro method of measuring the

chemotaxis of polymorphonuclear leukocytes from peripheral blood calculated a chemotactic index.

The mean chemotactic index in 31 patients with

diabetes mellitus was significantly less (p. less than 0.0005) than that
in 31 matched controls.

They found that the defect in chemotaxis could

not be correlated with plasma insulin, plasma glucose, serum C02 and blood
urea nitrogen values or with any therapeutic agents.

The defect in chemo-

taxis of the diabetic leukocytes was corrected by incubation of the cells
with insulin.

Insulin was found to be ineffective in the absence of glu-

cose.
Golub 35 et al., (1982) found in their study that diabetes in rats
inhibits the migration of neutrophils into the healing gingival crevice.
A decreased crevicular leukocyte response in vivo was detected as early
as 4 days after diabetes was induced.
Manouchehr 36 et. al., (1981) in their study on PMN chemotactic response in diabetic patients and periodontal disease demonstrated that
diabetic patients and severe periodontitis have significant impairment of
PMN chemotaxis.

In contrast, diabetic patients and mild periodontal dis-

ease as well as nondiabetic subjects and either severe or mild periodontitis did not show such impairment.

They indicated that the impairment

of PMN chemotaxis may be important in the pathogenesis of server periodontitis in diabetic patients.
It is commonly stated that patients with diabetes mellitus are more
susceptible to infections.

It appears that in the diabetic patient the

function of leukocytes in inflammation is hampered.

A decrease in
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glycolysis, inability of the diabetic leukocyte to phagocytize and a defect in leukotaxis can play a role in abnormal leukocyte function; or a
multifactorial problem may be evident.

These abnormalities of the leuko-

cyte could contribute to increased infections in the uncontrolled diabetic
patient.
The evidence that diabetes mellitus is related to functional disorders of neutrophils suggested the study of inflammation in streptozotocin induced diabetes mellitus.

This study measures the neutrophilic in-

filtration in a simple mucosal wound in rats and the detection of nitroblue
tetrazolium reaction of blood neutrophils.

MATERIALS AND METHOD
Eight male Holtzman* rats, averaging 250 grams each in weight, were
divided into two groups:

Control group A and experimental group B.

All

animals were housed separately to help minimize stress and the possibility
of cross infection.

They were maintained on Purina Rat Chow** and water.

The water was contained in a graduated bottle and was available ad libitum.
The daily water consumption for each animal was recorded.
The control group A consisted of four rats which were not injected
with streptozotocin.*** The experimental group B consisted of four rats
which were intraperitoneally (I.P.) injected with streptozotocin (65 mg/kg
in lee citrate buffer solution).

The animals were anesthetized using

diethyl ether to aid in injecting the streptozotocin.
The streptozotocin was weighed out (0.02 grams) and placed into each
of four small dark bottles.

A citrate buffer solution was prepared for

addition to the streptozotocin.

Two solutions were initially made.

Solu-

tionA, consisted of 1.382 grams Na citrate diluted with 100 ml. NaCL 9.9%.
In solution B, 1.114 grams of citric acid were diluted with 100 ml :of 0.9%
NaCL.

Solution A was added to solution B until a pH of 4.5 was obtained.
A lee Tuberculin syringe was filled with the prepared citrate buffer

solution and injected into the dark bottle containing 0.02 grams of
* Lock-Ericson Labs, Melrose Park, Illinois
** Scientific Small Animal Co., Arlington Heights, Illinois
*** Upjohn Co., Kalamazoo, Michigan
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streptoxotocin.

The contents was then mixed thoroughly and lee of the

mixture was withdrawn by syringe.

The lee streptozotocin mixture was

then injected I.P. into the anesthetized animal.

The animal was then re-

turned to its respective cage for recovery.
After seven days all the animals within group B were weighed and
clinically evaluated for diabetes mellitus.

The criteria recorded in

evaluating the diabetic state of the experimental animals were: increased
water consumption (the percent of consumption was estimated daily thru
the use of the graduated water bottle), glucosuria (evaluated thru use of
Tes-Tape* on a urine sample) and hyperglycemia (evaluated through use of
Dextrostrip** on a blood sample).

The above diagnostic tests were also

made with control group A to insure that these animals were not diabetic.
Linear incisions 0.5 em. in length were made in the palatal attached
incisions 0.5 em in length were made in the palatal attached gingivae and
extended posteriorly to the left maxillary incisor in each rat.

An Amer-

ican Standard 20/21 scalpel was utilized to make the incisions.
One member of each group was sacrificed with a lethal dose of diethyl
ether at the following intervals: 3, 6, 12 and 24 hours postoperatively.
The surgical and corresponding non-surgical site of attached gingivae were removed by block dissection.

The tissue samples were fixed in

10% neutral formalin for eight hours and prepared by conventional
logic techniques for evaluation.

histo~

The specimens were washed in tap water

overnight, dehydrated in ascending alcohols, cleared in xylene and embedded
* Lilly Co., Indianapolis, Indiana
**Ames Co., Elkhart, Indiana
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in paraffin blocks.

Ten sections approximately six microns in thickness

were obtained from each specimen site and were stained with hematoxylin
and eosin (Hand E) in order to obtain a microscopically measureable comparison of the healing sites between groups A and B.
Blood samples were taken at the time of sacrifice and thin smears
were prepared on slides and stained using NBT* procedure.

0.1 ml

solution (Reagent A') was transferred to a siliconized vial.

NBT

0.1 ml of

well mixed heparinized blood was added to the vial and mixed gently by
rolling the vial.

The vial was incubated at 37°C for fifteen minutes then

removed and let stand at room temperature an additional fifteen minutes.
The heparinized blood-NBT mixture was transferred onto a clean glass slide
and a smear was made.

The slides were then stained with Wright stain.

Polymorphonuclear leukocyte (PMN) counts were made from each tissue
specimen by counting the numbers of neutrophils within a 300 micron square
area along the edge of the incised wound beneath the level of epithelium.
The corresponding control tissue sections similarly were quantitatively
evaluated and recorded.
The blood slides were examined and evaluated for positive or negative
NBT activity within each group.
The sections from the gingival wounds were stained with H and E and
were examined with an A0-10 Star** microscope at a 450X's magnification.
The connective tissue in the lamina propria immediately adjacent to the
incision was selected for counting PMN's.

* NBT test, Sigma Co., St. Louis, Missouri
** AO Co., Buffalo, Ney York

An ocular eyepiece with a 100
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micron square reticular was used as a guide in scanning the connective
tissue.

All counts were made within 300 microns parallel to the cut sur-

face of the lamina propria.

PMN's were identified and microscopic counts

from nine 100 micron square fields were recorded.

The mean per 100 micron

square was calculated and recorded.
The NBT activity in the blood smears were recorded only according
to the frequency of NBT positive or negative PMN's in each of the specimens, per 100 micron square field.

RESULTS
The four rats injected with streptozotocin were diagnosed as diabetic.

Each diabet1c animal demonstrated increased water consumption (Table

1), an elevated blood glucose level (Table 2) and glucosuria.
The average water consumption for the control group was approximately 8% of total water volume per day.

The average water consumption for

the diabetic group was approximately 12% of the total water volume per day.
Blood glucose levels for control and diabetic animals were determined using Dextrostix, expressed in mg. glucose/dl. blood.

All control

animals fell into the 90 mg. glucose/dl. blood range (Table 2).
the diabetic

ani~als

Three of

(3-0, 12-D and 24-D) had blood glucose levels of 175

mg. glucose/dl. blood, and one (6-D) had a blood glucose level of 130 mg.
glucose/dl. blood (Table 2).

The Tes-tape analysis of urine samples for

the control group was normal.

For the diabetic animals the urine sugar

level was markedly elevated.
PMN counts for both groups can be found in Table 3 and Figures 1, 2
and 3.

The average number of PMN 1 s per 100 micron squared for the control

group ranged from 19.3 PMN s per 100 micron squared for the 3 hour animal
1

to the maximum number at 6 hours (27.8 PMN s per 100 micron square).
1

In

the diabetic group the 3 hour value was the lowest (11.0 PMN•s per 100
microns squared) and the maximum value was reached at the 12 hour interval
(26.0 PMN s per 100 micron squared).
1

As seen in Table 4, the NBT test of the blood smear was positive for
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Figure 1 - Frequency distribution of polymorphonuclear leukocytes
at the site of gingival incision wounds per 100 micron
squared field ~n control group.
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Figure 2 - Frequency distribution of polymorphonuclear leukocytes
at the site of gingival incision wounds per 100 micron
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Figure 3 - Frequency distribution of polymonuclear
leukocytes at the site of gingival
incision wounds per 100 micron squared
field in control and diabetic animals.
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the entire control and diabetic groups.
The findings in this experiment were not subJected to statistical
analysis.
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Table 1 - Daily water consumption for control and diabetic
animals, ml. %consumed daily over a seven day
period using a calibrated water bottle.
Animal #

DAYS
1

1-Control
2-Control
3-Control
4-Control
5-Diabetic
6-Diabetic
7-Diabetic
8-Diabetic

Ave.
day

2

3

4

5

6

7

10

5

10

10

10
5
10
20
15
10

10
10
20
20
15
10

5
10
10
5
10
10
15
20

10
10
10
10
10
10
15
10

5
5
10
10
20
20
10
15

10
5
10
10
10
5
10
15

5
10
5
10
10
10
10
10

7
8
9
8
12
13
12
12

Table 2 - Approximate blood glucose level in control and
diabetic animals, using Dextrostix {mg. glucose/
dl. blood).

Animal #
1-Control
2-Control
3-Control
4-Control
5-Diabetic
6-Diabetic
7-Diabetic
8-Diabeti c

mg. glucose/dl. blood
90
90
90
90
175
130
175
175
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Table 3 - Polymorphonuclear leukocytes in healing incision
wounds of the gingivae in nine 100 micron squared
fields.

3 hr.

CONTROL

DIABETIC

21
16
17
20
23
27
14
25

13
15
9
12
7
18
10
4

Ave.= 19.3

Ave.= 11.0

11

11

6 hr.

35
26
24
30
27
22
31
29
27

Ave.= 27.8

19
13
15
21
17
20
14
10
18

Ave.=16.3

12 hr.

26
30
18
24
27
21
32
28
16

Ave.= 23.6

31
33
27
19
26
23
17
30
28

Ave.= 26.0

24 hr.

21
16
13
10
23
18
15
19
17

Ave.=16.6

24
13
18
16
21
20
17
15
22

Ave.= 18.4
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Table 4 - Qualitative results of NBT test in blood smears Control vs. Diabetic.

HOUR

CONTROL

DIABETIC

3 hr.

+

+

6 hr.

+

+

12 hr.

+

+

24 hr.

+

+

DISCUSSION
Four rats injected intraperitoneally with streptozotocin exhibited
clinical signs of diabetes mellitus after seven days.

Over this seven day

period the daily water consumption for the diabetic rats significantly increased in comparison to the non-diabetic animals.

The streptozotocin in-

duced diabetic rats consumed an average of 12 ml of water daily while the
non-diabetic rats consumed an average of 8 ml of water daily.

This poly-

dipsia was a result of the increase in blood glucose in the diabetic rats.
The diabetic rats exhibit marked increases of glucose in the blood
and urine as measured with Tes-tape and Dextrostix, with this increase in
glucose indicative of a diabetic state.

The normal range for blood glucose

is approximately 80-120 mg/dl. 37 The control animals blood glucose level
is 90 mg/dl and falls into the normal range.

Three of the four experimen-

tal rats had blood glucose levels of 175 mg/dl, while the fourth rat had a
blood glucose level of 130 mg/dl, all of which are above the normal range.
Additional evidence of diabetes in the rats is the excessive glucose in the
urine.
This study confirms the results of Rakieten, et. al., in 1963 that
diabetes may be experimentally produced in laboratory rats by the intraperitoneal injection of streptozotocin, which causes pancreatic islet beta
cell necrosis.

The rats exhibited abnormally high blood and urine glucose

levels, polydipsia, polyuria and polyphagia.

This destruction of the pan-

creatic beta cells results in an increased blood glucose level due to a
32
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lack of insulin.
The increase in water consumption by the diabetic rats in this study
can be attributed to the elevated blood sugar levels. Guyton (1976) states
'

that the elevated. blood glucose has a dehydrating effect on the tissue
cells.

The elevated blood glucose has an osmotic diuretic effect on the

kidney tubules, resulting in polyuria.

Hence, the polydipsia is due to de-

hydration resulting from polyuria.
Infiltration of polymorphonuclear leukocytes into the healing wound
of streptozotocin induced diabetic rats parallels those studies done by
Hill, Perillie, Ward aDd Becker, and Robertson and Polk.

When compared to

the non-diabetic rats, the streptozotocin induced diabetic rats exhibit a
delay in polymorphonuclear leukocyte response.

This difference appears to

manifest itself in the early stages of wound healing.

There is a greater

difference of PMN leukocyte response between the diabetic and non-diabetic
rats in the 3 hour wound (an average difference of 8 PMN s per 300 X 300m 2
1

area) and the 6 hour wound (an average difference of 11 PMN•s per 300 X 300
m2 area).

At 3 and 6 hours the wounds in the non-diabetic animals had a

greater infiltration of PMN 1 s in the same corresponding wounds compared to
the diabetic animals.

However, in the 12 hour and 24 hour wound sites,

there appears to be no significant difference in PMN leukocyte response between the diabetic and non-diabetic rats.

Interestingly, this delay of

PMN leukocyte response in the diabetic rats as seen in the early stages of
wound healing is not evident as the wound healing process progresses. This
early delay in PMN leukocyte response in the diabetic animal may be attributed to a variety of factors, none of which is conclusive.
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Hill {et. al., 1973) in his study on impaired luekocyte responsiveness, suggests a deficient chemotactic stimulus may cause the delay in
leukocyte response.

If this is the case in this study, evidently the che-

motactic stimulus, while inhibited at the early phases of wound healing in
the diabetic rats, becomes restored as the wound healing phenomena progresses.

Similarly, if the delay in PMN leukocytes response is attributed to

deficient chemotactic factors, then an increase or pronounced expression of
such chemotactic factors may account for the increase in PMN leukocyte response in the 12 hour and 24 hour wounds.

An explanation for this change

in neutrophil chemoattraction is suggested by Ward {1970), that upon destruction or death of the PMN at the site of inflammation, lysosomal factors
are released which are chemotactic for PMN's.

This may account for the in-

crease in PMN response at the later stages of wound healing.
Perillie {et. al., 1962) shows that the early granulocyte phase of
local cellular response is significantly delayed and diminished in patients
with acidosis in comparison with normal and non-acidotic patients.

In this

study the delay in PMN leukocyte infiltration into the healing wounds of
diabetic rats as compared to non-diabetic rats may also be due to acidosis.
As the streptozotocin induced diabetic rats all show severe clinical signs
of diabetes, the associated acidosis may in part be a factor for the early
delay of PMN leukocytes at the healing wound site.
Ramamurthy and co-workers {1979) in their research found that diabetes
inhibits the migration of PMN's into the rat gingival crevice during the
early inflammatory phases of wound healing.
results in this study.

This is consistent with the

The migration of PMN's in the diabetic animals is
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inhibited during the early phases of wound healing.

The PMN response dur-

ing the later stages of wound healing in the diabetic animals appears to
increase, more closely approximating the PMN response in the control animals.

This initial delay of PMN migration in the diabetic animals during

the early stages of wound healing may be due to a number of factors.

Ward

and Becker in 1970, showed that leukotaxis is impaired when there is a depletion of potassium.

They theorize that the decreased potassium concen-

tration in the extracellular fluid of diabetics in the acidotic state, may
inhibit enzyme systems reducing the ability of the leukocytes of diabetics
to respond to a chemotaxis stimulus. However, their theory does not account
for the correctable PMN response seen at the later stages of wound healing
in this study.
Marble (1952), and Wertman and Henney (1961) in their studies hypothesized that the subnormal phagocytizing capacity of the leukocyte was one
of the possible causes of reduced resistance of the diabetic to infection.
Robertson and Polk (1974) showed that hyperglycemia alone led to decreased
phagocytosis, decreased diapedesis and a decrease in intracellular killing
of bacteria by PMN's.

Drachman (et. al., 1966) showed that the phagocytic

capabilities of PMN's are affected by the high levels of glucose in the
tissues of chronically diabetic rats.
This study parallels the results reported by Miller and Baker.

As

there appears to be no observable defect of phagocytosis in the diabetic
and non-diabetic rats as measured by the NBT test.

Both diabetic and non-

diabetic rats exhibited the reduction of nitroblue tetrazolium dye to a
blue formazan pigment.

Moreover, this positive NBT test for phagocytosis
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was exemplified at both early and later stages of wound healing.

SUMMARY AND CONCLUSIONS
Eight male Sprague Dawley rats were experimentally made chemically
diabetic by injecting streptozotocin.

Seven days after the injection of

the diabetogenic agent, the rats were clinically diagnosed as having diabetes mellitus.

The diagnosis was confirmed by polydipsia, glycosuria,

hyperglycemia and loss of weight.
The diabetic and non-diabetic animals were then subjected to a palatal incision wound and sacrificed at the following time intervals: 3, 6,
12 and 24 hours.

The corresponding tissue sections were excised and fixed

in 10% formalin and prepared according to conventional histologic technique
utilizing hematoxylin and eosin staining procedures.

Polymorphonuclear

leukocyte (PMN) counts were made from each tissue specimen by counting the
numbers of neutrophils within a 300 micron square area along the edge of
the incised wound beneath the level of epithelium.

The corresponding con-

trol tissue sections similarly were quantitatively evaluated and recorded.
Blood samples were taken at the time of sacrifice and thin smears
were prepared and stained using NBT procedure.

The blood slides were ex-

amined and evaluated for positive or negative NBT activity within each
group.
The following conclusions can be drawn from this study:
1)

Diabetes can be produced experimentally in rats thru the
intraperitoneal injection of streptozotocin.

2}

Rats made diabetic exhibit polydipsia, glycosuria,
hyperglycemia and loss of weight.
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3)

There appears to be a delay in the response of PMN's
to the site of wound healing within 3 and 6 hour
post-injury diabetic rats.

4)

The delay of PMN's in diabetic animals appears to
correct itself within 12 to 24 hours post-injury.

5}

There appears to be no defect in the diabetic or
non-diabetic rats as to the ability of their PMN's
to phagocytize.

BIBLIOGRAPHY
1.

Munroe, J.F. and Shipp, J.C.: Glucose Metabolism in Leukocytes from
Patients with Diabetes Mellitus, with and without Hypercholesteremia. Diabetes, Vol. 14,, No. 9, 584, 1965.

2.

Kent, T.; Hart, M. and Shires, T.: Introduction to Human Disease,
Appleton-Century-Crofts, N.Y., 1979, p. 436.

3.

McGilvery, R.W.: Biochemistry, A Functional Approach, W.B. Saunders
Co., Phila., 2nd ed. 1979, pp. 721-723.

4.

Kent, T.; Hart, M. and Shires, T.: Introduction to Human Disease,
Appleton-Century-Crofts, N.Y., 1979, p. 436, p. 438.

5.

Guyton, A.: Medical Physiology, W.B. Saunders Co., Philadelphia,
5th ed. 1976, 1046-1050.

6.

Bloom, W. and Fawcett, D.: Histology, W.B. Saunders Co., Philadelphia,
lOth. ed. 1975, p. 740.

7.

Junod, A.; Lambert, A.E. and Orci, L.: Studies of the Diabetogenic
Action of Streptozotocin, Cancer Chemotherapy Rep. 29:91-98, 1963.

8.

Belanti, J.: Immunology II, W.B. Saunders Co., Philadelphia, 1978,
pp. 32-33.

9.

Boggs, D. and Winkelstein, A.: White Cell Manual, F.A. Davis, Co.,
Philadelphia, 3rd ed., 1975, pp. 13-19.

10.

Hurley, J.V.: Acute Inflammation, W.B. Saunders Co., Philadelphia,
1979, pp. 90-101.

11.

Baehner, R.L. and Nathan, D.G.: Quantitative Nitroblue Tetrazolium
Test in Chronic Granulomatous Disease. New England Journal of
Medicine, 1968, pp. 278, 971-976.

12.

Marble, A., White, H. and Fernald, A.: The Nature of the Lowered
Resistance to Infection in Diabetes Mellitus, J. Clin. Invest.
17:423, 1938.

13.

Esmann, V.:

14.

Drachman, R.H.: Root, R.K. and Wood, W.B.: Studies on the Effect of
Experimental Nonketotic Diabetes Mellitus on Antibacterial
Defense. J. Exp. Med. 124:227, 1966,
39

The Diabetic Leukocyte, Enzyme, 13:32, 1972.

40
15.

Perillie, P., Nolan, J. and Finch, S.: Studies of the Resistance to
Infection in Diabetes Mellitus: Local Exudative Cellular Response.
J. Lab. and Clin. Med., Vol. 59, No. 6, 1008-1015, 1962.

16.

Martin, S.P., McKinney, G.R., Green, R. and Becker, C.: The Influence
of Glucose, Fructose and Insulin on the Metabolism of Leukocytes
of Healthy and Diabetic Subjects. J. Clin. Invest. 32:1171, 1953.

17.

Dumm, M.E.: Glucose Utilization and Lactate Production by Leukocytes
of Patients with Diabetes Mellitus. Proc. Soc. Exp. Biol. Med.
95:571, 1957.

18.

Esmann, V.: Effect of Cell Concentration on the Metabolism of Normal
and Diabetic Leukocytes in Vitro. Metabolism, 13, 354, 1964.

19.

Forscher, B.K. and Cecil, H.C.: Some Effects of Alloxan Diabetes on
Acute Inflammation. J. Appl. Physiology, 13:278, 1958.

20.

Esmann, V.:
1963.

21.

Marble, A.: Treatment of Diabetes Mellitus, Lea and Febiger,
Philadelphia, 1952.

22.

Wertman, K.F. and Henney, M.R.: The Effects of Alloxan Diabetes on
Phagocytosis and Susceptibility to Infections. J. Immunol.
89:314, 1962.

23.

Bybee, J. and Rogers, D.: The Phagocytic Activity of Polymorphonuclear
Leukocytes Obtained from Patients with Diabetes Mellitus, J. Lab.
Clin. Med., Vol. 64, Number 1, 1964.

24.

Drachman, R.H., Root, R.K. and Wood, W.B.: Studies on the Effect of
Experimental Nonketotic Diabetes Mellitus on Antibacterial Defense.
J. Exp. Med. 124:227, 1966.

25.

Miller, M.E. and Baker, L.: Leukocyte Functions in Juvenile Diabetes
Mellitus: Humoral and Cellular Aspects. J. Pediatr. 81:979, 1972.

26.

Cruckshank, A.H. and Payne, T.: Anti-Pneumococcal Power of the Blood
in Alloxan Diabetes in the Rabbit, Bull. Johns Hopkins Hospital.
84:334, 1948.

27.

Richardson, R.: Immunity in Diabetes: Influence of Diabetes on the
Development of Antibacterial Properties in the Blood. J. Clin.
Invest. 12:1143, 1933.

28.

Cantonzaro-Guimaraes, S.A.: Morphological Study of Wound Healing in
Alloxan-Diabetic Rats, Estomatol. Cult. 2:41, 1968.

Effect of Insulin on Human Leukocytes.

Diabetes, 12:545,

41
29.

Steerman, R.L.; Snyderman, R.; Lefkin, S.L. and Colten, H.R.:
Instrinsic Defect of the PMN Leukocyte in Impaired Chemotaxis
and Phagocytosis, Clin. Exp. Immunol. 9:939, 1971.

30.

Miller, M.E.; Norman, M.E., Koblenzer, P.J. and Schonauer, T.:
A New Familiar Defect of Neutrophil Movement. J. Lab. Clin.
Med. 82, 1:1, 1973.

31.

Hill, H.; Sauls, H.; Dettloff, J. and Quie, P.: Impaired Leukotactic
Responsiveness in Patients with Juvenile Diabetes Mellitus.
Clinical Immunology and Immunopathology 2, 395-403, 1974.

32.

Ward, P.A. and Becker, E.L.:

33.

Goetzl, E.J. and Austen, K.F.: Stimulation of Human Neutrophil
Leukocyte Aerobic Glucose Metabolism by Purified Chemotactic
Factors. J. Clin. Invest. 53:591, 1974.

34.

Mowat, A.G. and Baum, J.: Chemotaxis of PMN Leukocytes from Patients
with Diabetes Mellitus. New Eng. J. Med. 284:621, 1971.

35.

Golub, L.; Nicoll, G.; Iacono, V. and Ramamurthy, N.: In Vivo
Crevicular Leukocyte Response to a Chemotactic Challenge:
Inhibition by Experimental Diabetes. Infection and Immunity;
Vol. 37, No. 3, 1982.

36.

Manouchehr, M.; Spagnuolo, P.J.; Rodman, H.M. and Bissada, N.F.
Comparison of Neutrophil Chemotactic Response in Diabetic
Patients with Mild and Severe Periodontal Disease. J. Periodontology, 52(8) 410-415, 1981.

37.

Kent, T.; Hart, M. and Shires, T.: Introduction to Human Disease.
Appleton-Century-Crofts. N.Y. 1979 p. 436.

Life Science 9, 355, 1970.

APPROVAL SHEET
The thesis submitted by James L. Discipio has been read
and approved by the following committee:
Dr. Patrick Toto, Director
Professor, Oral Pathology, Loyola
Dr. Joseph Keene
Associate Professor, Periodontics, Loyola
Dr. Anthony Gargiulo
Professor, Periodontics, Loyola
The final copies have been examined by the director
of the thesis and the signature which appears below
verifies the fact that any necessary changes have
been incorporated and that the thesis is now given
final approval by the Committee with reference to
content and form.
The thesis is therefore accepted in partial fulfillment of the requirements for the degree of Master
of Science in Oral Biology.

42

